ABSTRACT Background and Aim Ferroptosis signaling pathway has been revealed to play a biological role in the tumorigenesis of colorectal cancer (CRC). Our aim was to evaluate the expression pattern and clinical potentials of two ferroptosis‐related genes FSP 1 and ACSL4 in colorectal tumors. Methods Thirty colorectal tumor tissues and thirty adjacent healthy tissues were subjected to gene expression study. Total RNA extraction from all tissues was completed and cDNA was synthesized from RNA. A qPCR was used for the gene expression analysis. Expression data were evaluated by SPSS software and the clinical importance of the genes was evaluated by ROC test. Results Based on our results, the expression levels of ACSL4 gene in the tumor tissues significantly down‐regulated compared to the healthy tissues ( p = 0.0005). However, the expression levels of FSP1 did not show a significant difference in the tumor cancer tissues in comparison with the healthy tissues ( p = 0.65). Furthermore, the expression levels of ACSL4 in CRC patients were reversely correlated with the high grade poorly differentiated tumors ( p = 0.0003, r = ‐0.54). Analysis of the diagnostic value of ACSL4 using ROC test showed an area under the curve (AUC) of 0.78 (95% CI: 0.6143–0.9229), with a sensitivity of 80% and a specificity of 60% (95% CI: 0.4060–0.7734) and a cut‐off of 1.3. Conclusion The expression levels of ACSL4 , but not FSP1 , increased significantly in colorectal tumor tissues in comparison with non‐tumor healthy tissues. Based on clinical analysis, it was indicated that ACSL4 has clinical potentials as a diagnostic biomarker in CRC.
Fardsanei et al. (Fri,) studied this question.